What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Breast cancer
Alain Fourquet mainly focuses on Breast cancer, Surgery, Radiation therapy, Internal medicine and Oncology.
The subject of his Breast cancer research is within the realm of Cancer.
His work deals with themes such as Clinical trial and Hazard ratio, which intersect with Surgery.
His Radiation therapy research includes elements of Whole Breast Irradiation, Cosmesis, Mammary gland and Mastectomy, Lumpectomy.
The study incorporates disciplines such as Gastroenterology and Gynecology in addition to Internal medicine.
The concepts of his Oncology study are interwoven with issues in Adjuvant therapy, Ovarian cancer and Cohort.
His most cited work include:
- Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial (802 citations)
- Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. (785 citations)
- Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer (578 citations)
What are the main themes of his work throughout his whole career to date?
Breast cancer, Internal medicine, Radiation therapy, Oncology and Surgery are his primary areas of study.
The various areas that Alain Fourquet examines in his Breast cancer study include Stage and Radiology.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
His study explores the link between Radiation therapy and topics such as Nuclear medicine that cross with problems in Tomotherapy and Radiation treatment planning.
His biological study spans a wide range of topics, including Gynecology, Metastasis and Early breast cancer.
His Surgery study frequently involves adjacent topics like Breast surgery.
He most often published in these fields:
- Breast cancer (60.70%)
- Internal medicine (47.82%)
- Radiation therapy (45.63%)
What were the highlights of his more recent work (between 2016-2021)?
- Breast cancer (60.70%)
- Radiation therapy (45.63%)
- Internal medicine (47.82%)
In recent papers he was focusing on the following fields of study:
Alain Fourquet spends much of his time researching Breast cancer, Radiation therapy, Internal medicine, Oncology and Radiology.
His Breast cancer research integrates issues from Stage, Nuclear medicine and Lymph node.
Surgery covers Alain Fourquet research in Radiation therapy.
His Surgery study combines topics in areas such as Toxicity and Cohort.
His Oncology research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Incidence and Trastuzumab.
His work in Radiology addresses issues such as Single Center, which are connected to fields such as Tomotherapy.
Between 2016 and 2021, his most popular works were:
- Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial. (62 citations)
- Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy (42 citations)
- Preoperative breast radiation therapy: Indications and perspectives. (22 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Breast cancer
His main research concerns Breast cancer, Radiation therapy, Internal medicine, Oncology and Radiology.
His research on Breast cancer focuses in particular on Mastectomy.
His biological study spans a wide range of topics, including Retrospective cohort study and Hazard ratio.
His Oncology study incorporates themes from Incidence, Cumulative incidence, Trastuzumab, Randomized controlled trial and Cohort.
The Radiology study combines topics in areas such as Concomitant and Cardiotoxicity.
His Surgery research incorporates elements of Pulmonary toxicity, Toxicity and Acute toxicity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
